PTPN22 and neoplasm: A recent study demonstrated that, despite showing enhanced anti-tumor effector capacity, under conditions of chronic, strong antigenic stimulation, Ptpn22-/- CD8+ T cells adopt an exhausted phenotype more rapidly than WT counterparts33 (Figure 2).